JP2025519106A5 - - Google Patents
Info
- Publication number
- JP2025519106A5 JP2025519106A5 JP2024569222A JP2024569222A JP2025519106A5 JP 2025519106 A5 JP2025519106 A5 JP 2025519106A5 JP 2024569222 A JP2024569222 A JP 2024569222A JP 2024569222 A JP2024569222 A JP 2024569222A JP 2025519106 A5 JP2025519106 A5 JP 2025519106A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- apolipoprotein
- lipid
- modified
- lipid nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2031977 | 2022-05-24 | ||
| NL2031977 | 2022-05-24 | ||
| EPPCT/EP2022/076593 | 2022-09-23 | ||
| PCT/EP2022/076593 WO2023046931A1 (en) | 2021-09-23 | 2022-09-23 | Apolipoprotein fusion proteins for cell-specific immune regulation |
| EP23165273.6 | 2023-03-29 | ||
| EP23165273 | 2023-03-29 | ||
| PCT/EP2023/063967 WO2023227682A1 (en) | 2022-05-24 | 2023-05-24 | Modified apolipoproteins with a targeting body for lipid nanoparticles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025519106A JP2025519106A (ja) | 2025-06-24 |
| JP2025519106A5 true JP2025519106A5 (https=) | 2026-04-03 |
Family
ID=86424775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024569222A Pending JP2025519106A (ja) | 2022-05-24 | 2023-05-24 | 脂質ナノ粒子用のターゲティング体を有する修飾アポリポタンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20260041638A1 (https=) |
| EP (1) | EP4532026A1 (https=) |
| JP (1) | JP2025519106A (https=) |
| KR (1) | KR20250029793A (https=) |
| CN (1) | CN119546627A (https=) |
| AU (1) | AU2023277740A1 (https=) |
| CA (1) | CA3254811A1 (https=) |
| IL (1) | IL317201A (https=) |
| MX (1) | MX2024014330A (https=) |
| WO (1) | WO2023227682A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025073054A1 (en) | 2023-10-05 | 2025-04-10 | Nanovation Therapeutics Inc. | Method of delivery of dna or rna cargo using unshielded lipid nanoparticles |
| WO2025190968A1 (en) | 2024-03-11 | 2025-09-18 | Bio-Trip B.V. | Apolipoprotein lipid nanoparticle |
| CN119499247A (zh) * | 2024-11-22 | 2025-02-25 | 中国农业大学 | 一种改善或治疗肠道炎症的双载药重组高密度脂蛋白纳米颗粒及其制备方法和应用 |
| CN121059567A (zh) * | 2025-11-07 | 2025-12-05 | 中国医学科学院输血研究所 | 一种脂质纳米颗粒及其应用、药物递送载体 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013125769A1 (ko) * | 2012-02-24 | 2013-08-29 | 성균관대학교 산학협력단 | 아포리포단백질을 포함하는 항체-약물 결합체 |
| KR102440820B1 (ko) * | 2015-09-08 | 2022-09-05 | 테리피온, 인크. | ApoA-1 융합 폴리펩티드 및 관련 조성물 및 방법 |
| CA3222851A1 (en) | 2021-06-22 | 2022-12-29 | Roy VAN DER MEEL | Nucleic acid containing nanoparticles |
-
2023
- 2023-05-24 KR KR1020247041349A patent/KR20250029793A/ko active Pending
- 2023-05-24 AU AU2023277740A patent/AU2023277740A1/en active Pending
- 2023-05-24 EP EP23724893.5A patent/EP4532026A1/en active Pending
- 2023-05-24 WO PCT/EP2023/063967 patent/WO2023227682A1/en not_active Ceased
- 2023-05-24 IL IL317201A patent/IL317201A/en unknown
- 2023-05-24 CN CN202380042822.3A patent/CN119546627A/zh active Pending
- 2023-05-24 US US18/865,898 patent/US20260041638A1/en active Pending
- 2023-05-24 CA CA3254811A patent/CA3254811A1/en active Pending
- 2023-05-24 JP JP2024569222A patent/JP2025519106A/ja active Pending
-
2024
- 2024-11-19 MX MX2024014330A patent/MX2024014330A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025519106A5 (https=) | ||
| JP7676472B2 (ja) | 細胞療法に使用するための、免疫学的に識別できる細胞表面変異体 | |
| US20240166721A1 (en) | Cd33 exon 2 deficient donor stem cells for use with cd33 targeting agents | |
| JP7017506B2 (ja) | 系統特異的抗原の阻害のための組成物および方法 | |
| CN104936977B (zh) | 微管修饰化合物 | |
| JP2018531260A6 (ja) | 系統特異的抗原の阻害のための組成物および方法 | |
| JP2022517618A (ja) | 系統特異的抗原の阻害のための組成物および方法 | |
| US20260041638A1 (en) | Modified apolipoproteins with a targeting body for lipid nanoparticles | |
| CN119816517A (zh) | 编码靶向bcma的嵌合抗原受体的环状rna | |
| Streit et al. | Variable effects of the conserved RNA hairpin element upon 3′ end processing of histone pre-mRNA in vitro | |
| CN120390656A (zh) | 环状rna组合物 | |
| JP2023528415A (ja) | Ｃｒｉｓｐｒベースの塩基エディターシステムを使用した系列特異的抗原の阻害のための組成物及び方法 | |
| JP2025530627A (ja) | Ｅｒｖシンチチンで機能化された細胞外小胞及びカーゴ送達のためのその使用 | |
| CN120265314A (zh) | 抗体抗性修饰受体以增强基于细胞的疗法 | |
| EP4430186A1 (en) | Compositions and methods for erm2 modification | |
| WO2025096878A9 (en) | Rna for in vivo transfection with increased expression | |
| US20250375522A1 (en) | Chimeric checkpoint receptor for the use in treatment of malignant b-cell diseases | |
| WO2024152962A1 (zh) | 抗tt3的人源化抗体及其应用 | |
| RU2793803C2 (ru) | Иммунологически отличимые варианты поверхности клеток для применения в клеточной терапии | |
| WO2025079599A1 (ja) | サブセットレベルで細胞を標的化可能な担体およびその製造方法 | |
| KR20260062923A (ko) | 항-vista 항체 rna 또는 핵산 접합체(arc 또는 anc), 이를 함유하는 조성물 및 이의 치료 용도 | |
| EP4713459A2 (en) | Anti-vista antibody rna or nucleic acid conjugates (arcs or ancs), compositions containing, and therapeutic use thereof | |
| HK40014655B (en) | Immunologically discernible cell surface variants for use in cell therapy | |
| HK40014655A (en) | Immunologically discernible cell surface variants for use in cell therapy |